Effect of KRASᴳ¹² mutations on overall survival in patients with refractory metastatic colorectal cancer: a post-hoc analysis phase 3 SUNLIGHT trial

Effect of prior use of anti-VEGF agents on overall survival in patients with refractory metastatic colorectal cancer: post-hoc analysis of the phase 3 SUNLIGHT trial

Overall and progression-free survival of patients with metastatic colorectal cancer: a real-world prospective, longitudinal cohort study on the continuum of care

Phase Ib study of futibatinib plus pembrolizumab in patients with esophageal carcinoma: Updated results of antitumor activity and tolerability results in combination with chemotherapy